cp wire

CP Wire Articles

Intellia Therapeutics, Inc. (NASDAQ:NTLA),  announced on 5/14/18 the addition of new scientific advisors in immuno-oncology and autoimmunity. The advisors hail from prestigious international... read more

Mon, 05/14/18 - 10:03 am
CP Staff

Beam Therapeutics announced today that it is launching to develop precision genetic medicines that make edits to individual base pairs in the genetic code. Co-founded by scientific pioneers known... read more

Mon, 05/14/18 - 09:14 am
CP Staff

UCB announced on 5/14/18 that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the company's newest anti-epileptic drug (AED) Briviact (... read more

Mon, 05/14/18 - 08:57 am
CP Staff

Synaffix B.V. announced today the expansion of its Scientific Advisory Board (SAB) with the addition of Dr. John M. Lambert, the former Chief Scientific Officer of ImmunoGen, Inc.

Dr.... read more

Mon, 05/14/18 - 08:43 am
CP Staff

        ... read more

Fri, 05/11/18 - 10:04 am
CP Staff

AstraZeneca and MedImmune, announced on 5/11/18 top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary... read more

Fri, 05/11/18 - 09:52 am
CP Staff

Krystal Biotech Inc., (“Krystal”) (NASDAQ:KRYS), announced on 5/11/18 that the first patient has been dosed in the Phase 1/2, first in-human trial of KB103, a first-in-class topical gene therapy... read more

Fri, 05/11/18 - 09:27 am
CP Staff

Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced on 5/11/18 that the U.S. Food and Drug Administration’s... read more

Fri, 05/11/18 - 09:20 am
CP Staff

Cellectar Biosciences (Nasdaq:CLRB), announced on 5/10/18 that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to CLR 131, the... read more

Thu, 05/10/18 - 10:58 pm
CP Staff

Digital DNAtix Ltd., the genetics blockchain company, released its first open-source DNA Compression tool to GitHub today. It is almost impossible to transfer genetic data with current blockchain... read more

Thu, 05/10/18 - 01:14 pm
CP Staff

Eli Lilly and Company (NYSE: LLY) and ARMO BioSciences, Inc. (NASDAQ: ARMO) today announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an... read more

Thu, 05/10/18 - 10:17 am
CP Staff

Roche announced on 5/10/18 that the Phase III IMblaze370 study evaluating the combination of Tecentriq (atezolizumab) and Cotellic (cobimetinib) did not meet its primary endpoint of overall... read more

Thu, 05/10/18 - 09:52 am
CP Staff

Knopp Biosciences LLC  announced on 5/10/18 the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes (HES) met its co-primary... read more

Thu, 05/10/18 - 09:31 am
CP Staff

News of Novartis, AT&T, a Russian Oligarch, and others paying significant sums to President Trump's former attorney broke yesterday 5/8/18. It was initially reported that Novartis had paid a... read more

Wed, 05/9/18 - 02:24 pm
CP Staff

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), announced on 5/9/18 that it has concluded its review of all data outputs and corresponding analyses from its successfully completed Phase 2... read more

Wed, 05/9/18 - 09:42 am
CP Staff

Two sets of California patients living with HIV filed a personal injury lawsuit and a separate class action lawsuit against Gilead Sciences Inc. seeking to hold the Bay Area drug maker accountable... read more

Wed, 05/9/18 - 09:22 am
CP Staff

Michael Avenatti, Stormy Daniel's lawyer, has produced documents that show that a Russian Oligarch, AT&T, Novartis AG, and others have paid hundreds of thousands of dollars to Michael Cohen.... read more

Tue, 05/8/18 - 08:37 pm
CP Staff

Faron Pharmaceuticals Ltd ("Faron") (AIM: FARN), announced on 5/8/17 top line data from its pan-European Phase III INTEREST trial. The INTEREST study did not meet the Day 28 (D28) primary efficacy... read more

Tue, 05/8/18 - 03:45 pm
CP Staff

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH)  announced on 5/8/18 that, following the receipt of minutes from a recent meeting with the U.S. Food and Drug Administration (FDA), the Company has... read more

Tue, 05/8/18 - 03:22 pm
CP Staff

Neon Therapeutics, announced on 5/8/18 that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck’s anti... read more

Tue, 05/8/18 - 10:26 am
CP Staff


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.